Beyond the Prescription: A New Grant Aims to Mend Canada's Health System

OTTAWA, ON – June 29, 2026

The Health Research Foundation (HRF) today announced its 2026 Health System Solutions Grant, a national call for proposals that looks past the surface of healthcare delivery to target the very architecture of how Canadians access innovative care. While new funding for health research is always welcome news, this initiative signals a more profound and strategic intervention—one aimed squarely at the systemic cracks that too often delay or deny patients the benefits of modern medicine.

Backed by two tiers of funding, ranging from $50,000 for targeted initiatives to $250,000 for larger multi-site projects, the grant invites researchers, clinicians, and community organizations to propose tangible solutions. But the true significance of this call lies not in the dollar amounts, but in the problems it seeks to solve: the tangled pathways, bureaucratic hurdles, and structural disconnects that define the patient experience for many.

Targeting the System, Not Just the Symptoms

For decades, the conversation around healthcare innovation in Canada has often been dominated by the therapies themselves. This grant deliberately shifts the focus to the system that delivers them. The HRF has structured its call around two pillars that diagnose the core challenges hindering progress. The first, “Health System Factors Affecting Real-World Use and Outcomes,” confronts the labyrinthine journey patients must navigate. It asks applicants to scrutinize care pathways, referral processes, and system capacity—the very mechanics that determine whether an innovative medicine ever reaches the person who needs it.

This is a critical acknowledgment of a well-documented reality. A groundbreaking treatment is of little use if patients are not identified in a timely manner, if referral from a family doctor to a specialist takes months, or if hospitals lack the data infrastructure to integrate a new standard of care. The grant’s priority on “Improving the Patient Journey” is a direct mandate to map these frustrating and often inefficient routes and then draw new, more direct ones.

The second pillar, “Improving the Coherence and Performance of Review and Reimbursement,” tackles the notoriously complex world of health technology assessment (HTA), pricing, and funding. In Canada’s federated system, the path from a drug’s approval to its public reimbursement can be fraught with delays and inconsistencies. This pillar encourages research into how these fragmented processes interact and where the inefficiencies lie. It’s a bold attempt to bring evidence-based reform to the administrative side of healthcare, recognizing that systemic logjams are as detrimental to patient outcomes as any clinical barrier.

A Legacy of Investment and Strategic Partnership

This ambitious agenda is not emerging from a vacuum. The Health Research Foundation, established in 1964, has a 60-year history of investing in Canadian health innovation. Having granted over $30 million to more than 1,700 researchers, the organization has a long-standing commitment to improving the country’s healthcare landscape. This deep history provides the credibility and institutional knowledge necessary to guide such a targeted initiative.

Crucially, the HRF is generously funded by the members of Innovative Medicines Canada (IMC), the association representing Canada’s innovative pharmaceutical industry. This foundational relationship situates the grant at the intersection of public good and industry insight. While the HRF operates as an independent non-profit, its partnership with IMC ensures its work is informed by those at the forefront of medical discovery. This collaborative model is essential for bridging the gap between the creation of innovative medicines and their successful integration into the healthcare system.

In recent years, the foundation has sharpened its strategic focus, moving toward applied, system-focused research that promises demonstrable improvements. This 2026 grant is the culmination of that evolution, prioritizing multi-year projects designed to generate actionable evidence for health system leaders and support scalable solutions that can be adopted nationwide. It represents a mature understanding that transformative change requires more than just funding—it requires a coordinated effort between researchers, industry, government, and providers.

The Search for Actionable Solutions

The ultimate goal of the Health System Solutions Grant is to produce tangible change. This is evident in the language used by the foundation’s leadership. Christine Elliott, Chair of the HRF Board of Directors, states, “We are looking for bold, practical, and collaborative projects that generate actionable solutions to improve patient access, strengthen care coordination, and help health systems better integrate innovation into routine care.”

The emphasis on “bold, practical, and collaborative” is more than just rhetoric; it is a clear set of criteria for applicants. The call for proposals welcomes a wide array of applicants—from academic researchers and health system providers to not-for-profit and community-based organizations—encouraging the kind of multi-stakeholder partnerships that are essential for real-world implementation. A project that brings together patients, clinicians, and health administrators to co-design a new referral pathway, for instance, is precisely the kind of collaborative effort this grant is designed to foster.

Projects will be judged on their potential for scalability and broad system impact. The HRF is not looking for boutique solutions that work in only one clinic or for one specific condition. It is investing in models and evidence that can inform policy, reshape standards of care, and ultimately be adopted across jurisdictions. The requirement for measurable patient and system performance outcomes ensures that success is defined not by the completion of a research paper, but by a demonstrable improvement in the health and wellbeing of Canadians.

By focusing on implementation-focused research, the HRF aims to bridge the infamous gap between knowledge and practice. It is a direct challenge to the cycle of identifying problems without creating viable pathways to solve them. This initiative is a calculated investment in building a more responsive, efficient, and equitable healthcare system—one that ensures the promise of innovation becomes a reality for every patient. The deadline for initial Letters of Intent is July 22, 2026, marking the first step in what could be a pivotal new chapter for Canadian healthcare.